Synaptogenix Inc (SNPX)

[SF Wolf]

I don't see any problem with the share structure, there has been no insider selling, and there is no dilution or capital raise prior to Ph2b study results.

Personally, I believe, once we have Ph2b results in about 4 weeks the share structure will be a huge positive if the company decides to raise capital for further studies or allow a Big Pharma company to partner with it. The recent increase in authorized but NOT ISSUED shares will allow that.